These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 25887456

  • 1. Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.
    Mossallam SF, Amer EI, Ewaisha RE, Khalil AM, Aboushleib HM, Bahey-El-Din M.
    BMC Infect Dis; 2015 Mar 24; 15():147. PubMed ID: 25887456
    [Abstract] [Full Text] [Related]

  • 2. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE, Bahey-El-Din M, Mossallam SF, Amer EI, Aboushleib HM, Khalil AM.
    Exp Parasitol; 2014 Oct 24; 145():51-60. PubMed ID: 25092439
    [Abstract] [Full Text] [Related]

  • 3. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
    Abreu PA, Miyasato PA, Vilar MM, Dias WO, Ho PL, Tendler M, Nascimento AL.
    Infect Immun; 2004 Oct 24; 72(10):5931-7. PubMed ID: 15385496
    [Abstract] [Full Text] [Related]

  • 4. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
    Pinheiro CS, Ribeiro AP, Cardoso FC, Martins VP, Figueiredo BC, Assis NR, Morais SB, Caliari MV, Loukas A, Oliveira SC.
    Parasite Immunol; 2014 Jul 24; 36(7):303-12. PubMed ID: 24749785
    [Abstract] [Full Text] [Related]

  • 5. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
    Varaldo PB, Leite LC, Dias WO, Miyaji EN, Torres FI, Gebara VC, Armôa GR, Campos AS, Matos DC, Winter N, Gicquel B, Vilar MM, McFadden J, Almeida MS, Tendler M, McIntosh D.
    Infect Immun; 2004 Jun 24; 72(6):3336-43. PubMed ID: 15155638
    [Abstract] [Full Text] [Related]

  • 6. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni.
    Lam HYP, Huang SP, Liang TR, Wu WJ, Cheng PC, Chang KC, Peng SY.
    Parasitol Int; 2022 Feb 24; 86():102446. PubMed ID: 34481947
    [Abstract] [Full Text] [Related]

  • 7. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR, Batistoni de Morais S, Figueiredo BC, Ricci ND, de Almeida LA, da Silva Pinheiro C, Martins Vde P, Oliveira SC.
    PLoS One; 2015 Feb 24; 10(5):e0125075. PubMed ID: 25942636
    [Abstract] [Full Text] [Related]

  • 8. The effects of immunization with recombinant Sm14 (rSm14) in reducing worm burden and mortality of mice infected with Schistosoma mansoni.
    Ribeiro F, Vieira Cdos S, Fernandes A, Araujo N, Katz N.
    Rev Soc Bras Med Trop; 2002 Feb 24; 35(1):11-7. PubMed ID: 11873255
    [Abstract] [Full Text] [Related]

  • 9. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
    Fonseca CT, Pacífico LG, Barsante MM, Rassi T, Cassali GD, Oliveira SC.
    Microbes Infect; 2006 Aug 24; 8(9-10):2509-16. PubMed ID: 16914349
    [Abstract] [Full Text] [Related]

  • 10. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
    Ramos CR, Spisni A, Oyama S, Sforça ML, Ramos HR, Vilar MM, Alves AC, Figueredo RC, Tendler M, Zanchin NI, Pertinhez TA, Ho PL.
    Biochim Biophys Acta; 2009 Apr 24; 1794(4):655-62. PubMed ID: 19150418
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
    Varaldo PB, Miyaji EN, Vilar MM, Campos AS, Dias WO, Armôa GR, Tendler M, Leite LC, McIntosh D.
    FEMS Immunol Med Microbiol; 2006 Oct 24; 48(1):132-9. PubMed ID: 16965361
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
    Garcia TC, Fonseca CT, Pacifico LG, Durães Fdo V, Marinho FA, Penido ML, Caliari MV, de Melo AL, Pinto HA, Barsante MM, Cunha-Neto E, Oliveira SC.
    Acta Trop; 2008 Jun 24; 106(3):162-7. PubMed ID: 18423420
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
    Cardoso FC, Pacífico RN, Mortara RA, Oliveira SC.
    Clin Exp Immunol; 2006 Jun 24; 144(3):382-91. PubMed ID: 16734606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.